Deerfield/ Dana-Farber’s USD 130 Million Cancer Research Deal; FDA-Approval to BMS’ Breyanzi & TG Therapeutics’ Ukoniq; EU Marketing Rights for ViiV Healthcare’s Rukobia
Delveinsight
FEBRUARY 9, 2021
The move came not long after healthcare investor giant Deerfield Management has forged a partnership to create the Center for Protein Degradation, investing worth USD 80 million. European Marketing Authorisation to ViiV Healthcare’s Rukobia for Multidrug-resistant HIV. A lot has been achieved in the HIV treatment market sphere.
52 
Let's personalize your content